
Mineralys Therapeutics Insider Sold Shares Worth $43,350,000, According to a Recent SEC Filing

I'm PortAI, I can summarize articles.
03:38 AM EST, 11/24/2025 (MT Newswires) -- Brian Taylor Slingsby, 10% Owner, Director, on November 20, 2025, sold 1,000,000 shares in Mineralys Therapeutics ( MLYS ) for $43,350,000. Following the Form 4 filing with the SEC, Slingsby has control over a total of 7,903,838 common shares of the company, with 7,903,838 controlled indirectly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

